Contemporary Trend of Reduced-Dose Non-Vitamin K Anticoagulants in Japanese Patients With Atrial Fibrillation: A Cross-Sectional Analysis of a Multicenter Outpatient Registry

Journal of Cardiology - Japan
doi 10.1016/j.jjcc.2018.09.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Overview of the Non-Vitamin K Oral Anticoagulants for Atrial Fibrillation

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2017English

Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Novel Anticoagulants Versus Vitamin K Antagonists for Cardioversion of Non- Valvular Atrial Fibrillation – A Meta-Analysis of More Than 17000 Patients

Scientific Reports
Multidisciplinary
2019English

Role of Non-Vitamin K Oral Anticoagulants for Prevention of Stroke in Renal Impaired Atrial Fibrillation Patients

ACI (Acta Cardiologia Indonesiana)
2019English

Healthcare Costs of Stroke and Major Bleeding in Patients With Atrial Fibrillation Treated With Non–vitamin K Antagonist Oral Anticoagulants

Journal of Medical Economics
Health Policy
2019English

Prm20 - Clinical Effectiveness and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion

Journal of Clinical Trials in Cardiology
2017English

Safety of Once- Or Twice-Daily Dosing of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients With Nonvalvular Atrial Fibrillation: A NOAC-TR Study

Bosnian Journal of Basic Medical Sciences
Medicine
2017English

Non-Vitamin K Oral Anticoagulants Versus Warfarin for Patients With Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights

Cardiovascular Therapeutics
MedicineCardiovascular MedicinePharmacologyCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy